scispace - formally typeset
J

John G. Gums

Researcher at University of Florida

Publications -  165
Citations -  4000

John G. Gums is an academic researcher from University of Florida. The author has contributed to research in topics: Hydrochlorothiazide & Atenolol. The author has an hindex of 31, co-authored 160 publications receiving 3551 citations. Previous affiliations of John G. Gums include East Tennessee State University & American Association of Colleges of Pharmacy.

Papers
More filters
Journal ArticleDOI

Large-Scale Gene-Centric Meta-analysis across 32 Studies Identifies Multiple Lipid Loci

Folkert W. Asselbergs, +184 more
TL;DR: This large meta-analysis of lipid phenotypes with the use of a dense gene-centric approach identified multiple SNPs not previously described in established lipid genes and several previously unknown loci, suggesting that a focused genotyping approach can further increase the understanding of heritability of plasma lipids.
Journal ArticleDOI

Gene-centric Meta-analysis in 87,736 Individuals of European Ancestry Identifies Multiple Blood-Pressure-Related Loci

Vinicius Tragante, +139 more
TL;DR: The findings extend the understanding of genes involved in BP regulation, which may provide new targets for therapeutic intervention or drug response stratification and provide support for a putative role in hypertension of several genes.
Journal ArticleDOI

Outcome Analysis of a Pharmacist-Managed Anticoagulation Service

TL;DR: A pharmacist‐managed AMS in a family practice setting can result in improved outcomes for patients receiving warfarin and is cost effective in treating and preventing thromboembolic disorders.
Journal ArticleDOI

Loci influencing blood pressure identified using a cardiovascular gene-centric array

Santhi K. Ganesh, +144 more
TL;DR: Two novel loci associated with BP are identified and multiple previously reported associations are confirmed, extending the understanding of genes involved in BP regulation and some of which may eventually provide new targets for therapeutic intervention.
Journal ArticleDOI

Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study

TL;DR: This trial is to identify the genetic determinants of the antihypertensive and adverse metabolic responses to a thiazide diuretic, a beta-blocker, and their combination through candidate gene and genome-wide association approaches.